Follow-up to the ECVAM Prevalidation Study on In Vitro Tests for Acute Skin Irritation

The European Centre for the Validation of Alternative Methods (ECVAM) Skin Irritation Task Force was established in 1996, to review the status of the development and validation of alternative tests for skin irritation and corrosion, and to identify appropriate non-animal tests for predicting human skin irritation that were sufficiently well-developed to be prevalidated and validated by ECVAM. The EpiDerm™ method, based on a reconstituted human skin model, was proposed as being sufficiently well advanced to enter a prevalidation (PV) study. Based on a review of test protocols, prediction models (PMs), and data submitted by test developers on ten specified chemicals, with 20% sodium lauryl sulphate as a reference standard, the task force recommended the inclusion of four other tests: EPISKIN™ and PREDISKIN™, based on reconstituted human epidermis or on human skin; the non-perfused pig-ear test, based on pig skin; and the skin integrity function test (SIFT), with ex vivo mouse skin. The prevalidation study on these methods was funded by ECVAM, and took place during 1999–2000. The outcome of the PV study was that none of the methods was ready to enter a formal validation study, and that the protocols and PMs of the methods had to be improved in order to increase their predictive abilities. Improved protocols and PMs for the EpiDerm and EPISKIN methods, the pig ear test, and the SIFT were presented at an extended Task Force meeting held in May 2001. It was agreed that, in the short term, the performance of the revised and harmonised EpiDerm and EPISKIN methods, as well as the modified SIFT, should be evaluated in a further study with a new set of 20 test chemicals. In addition, it was decided that the SIFT and the pig-ear test would be compared to see if common endpoints (transepidermal water loss, methyl green-pyronine stain) could be identified.

[1]  V. Dixit,et al.  Keratinocytes as initiators of inflammation , 1991, The Lancet.

[2]  J. Knop,et al.  Is cytokine expression responsible for differences between allergens and irritants? , 1996, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[3]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[4]  K. G. Dossou,et al.  Use of in vitro skin recombinants to evaluate cutaneous toxicity: a preliminary study , 1992 .

[5]  K. Wilhelm,et al.  Individual, ethnic and seasonal variability in irritant susceptibility of skin: the implications for a predictive human patch test , 1996, Contact dermatitis.

[6]  M. Ponec,et al.  Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. , 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[7]  L. Kanerva Electron microscopy of the effects of dithranol on healthy and on psoriatic skin. , 1990, The American Journal of dermatopathology.

[8]  B. De Wever,et al.  Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles , 1999, Cell Biology and Toxicology.

[9]  K. Yoneda,et al.  An automated method for the quantification of immunostained human Langerhans cells. , 2001, Journal of immunological methods.

[10]  R Roguet,et al.  A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Chibout,et al.  Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products. , 2000, Toxicology and applied pharmacology.

[13]  G. Serrero,et al.  Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Primavera,et al.  Selective induction of cell-associated interleukin-1alpha in murine keratinocytes by chemical allergens. , 1998, Toxicology.

[15]  C. Willis,et al.  Experimentally‐induced irritant contact dermatitis , 1988, Contact dermatitis.

[16]  M. Rosdy,et al.  Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  G. Bryce,et al.  Ultrastructural effects of UVB radiation and subsequent retinoic acid treatment on the skin of hairless mice , 1991, Journal of cutaneous pathology.

[18]  D. Basketter,et al.  The classification of skin irritants by human patch test. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  J. Habowsky,et al.  Comparative ultrastructure and cytochemistry of epidermal responses to tape stripping, ethanol and vitamin A acid in hairless mice. , 1979, The Journal of investigative dermatology.

[20]  C. Cohen,et al.  Selective Induction of Interleukin-12 in Reconstructed Human Epidermis by Chemical Allergens , 1999, Alternatives to laboratory animals : ATLA.

[21]  A. Enk,et al.  Identification and induction of keratinocyte-derived IL-10. , 1992, Journal of immunology.